Skip to main content
3SBio Inc. logo

3SBio Inc. — Investor Relations & Filings

Ticker · 1530 ISIN · KYG8875G1029 LEI · 529900P0TQC1E9Y7FN31 HKEX Manufacturing
Open in API
Filings indexed 1,490 across all filing types
Latest filing 2026-05-06 Regulatory Filings
Country KY Cayman Islands
Listing HKEX 1530

About 3SBio Inc.

http://www.3sbio.com

3SBio Inc. is a biopharmaceutical enterprise specializing in the integrated research, development, production, and commercialization of innovative biopharmaceutical products. The company operates as a biotechnology firm, focusing on the discovery, development, manufacture, and marketing of biologics, with a particular emphasis on mammalian cell-based biopharmaceuticals. 3SBio addresses critical medical needs by providing an extensive range of products and services to markets both domestically and internationally.

Recent filings

Filing Released Lang Actions
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2026
Regulatory Filings
2026-05-06 English
NOTIFICATION LETTER AND REPLY FORM TO REGISTERED SHAREHOLDERS - Reminder letter regarding the Arrangement of Electronic Dissemination of Corporate Communications
Regulatory Filings Classification · 85% confidence The document is a letter to shareholders reminding them of the electronic dissemination arrangement for future corporate communications and soliciting email addresses. It does not contain financial statements, meeting materials, or proxy solicitation for a specific vote, nor does it announce a report’s publication date. It is a routine regulatory notice about shareholder communications. This fits the fallback “Regulatory Filings” category rather than a report, proxy, dividend, or other specific filing.
2026-04-29 English
NOTIFICATION LETTER AND REPLY FORM TO NON-REGISTERED SHAREHOLDERS - Reminder letter regarding the Arrangement of Electronic Dissemination of Corporate Communications
Regulatory Filings Classification · 78% confidence The document is a reminder letter to non-registered shareholders regarding the arrangement for electronic dissemination of corporate communications. It is neither a financial report, earnings release, meeting notice, proxy statement, nor a dividend or capital change announcement. It simply notifies shareholders of a corporate communications policy. This does not fit any specific category and therefore falls under the fallback “Regulatory Filings” category.
2026-04-29 English
2025 Environmental, Social and Governance Report
Regulatory Filings
2026-04-29 English
2025 ANNUAL REPORT
Regulatory Filings
2026-04-29 English
POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING HELD ON 23 APRIL 2026
Declaration of Voting Results & Voting Rights Announcements Classification · 97% confidence The document is an announcement from the company regarding the poll results of an Extraordinary General Meeting (EGM), detailing the number of votes for and against a resolution. This matches the definition of "Declaration of Voting Results & Voting Rights Announcements" (Code: DVA).
2026-04-23 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.